17 results
8-K
EX-99.1
SLRN
Acelyrin Inc
9 May 24
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
8:13am
Investor Presentations
ACELYRIN management will attend the Jefferies Global Healthcare Conference and Ms. Kim will participate in a moderated fireside
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
as a director of AgNovos Healthcare LLC. Ms. Svoronos previously served as a director of PTC Therapeutics, Inc. from June 2016 to December 2022, Global Blood
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
States Healthcare Laws
Healthcare providers and third-party payors in the United States and elsewhere play a primary role in the recommendation … and abuse and other healthcare laws and regulations, including, without limitation:
The federal Anti-Kickback Statute, which prohibits, among other
8-K
EX-99.1
SLRN
Acelyrin Inc
27 Nov 23
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
4:31pm
Sandler’s 35th Annual Healthcare Conference on Tuesday, November 28 or the 6th Annual Evercore ISI HealthCONx Conference on Thursday, November 30, 2023
8-K
EX-99
6hrd00o11bwd0
7 Nov 23
ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
4:23pm
10-Q
j6bw5uuqx3xq2nilso
15 Jun 23
Quarterly report
4:19pm
424B4
t762h9k
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
vbpwz90xtm
1 May 23
IPO registration (amended)
6:10am
S-1
EX-10.13
g2rb4e2l 3c
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.12
d6rhv
13 Apr 23
IPO registration
5:10pm
S-1
EX-4.2
gvct v6l04mpvv
13 Apr 23
IPO registration
5:10pm
S-1
EX-2.1
ks6g ialy5zpn8vti
13 Apr 23
IPO registration
5:10pm
S-1
54gs2fn3xuq3ns7
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next